Multiple Myeloma
Showing NaN - NaN of 258
Multiple Myeloma, High Risk Smoldering Multiple Myeloma Trial in United States (Ixazomib (MLN9708), Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- High Risk Smoldering Multiple Myeloma
- Ixazomib (MLN9708)
- Dexamethasone
-
Basking Ridge, New Jersey
- +5 more
Nov 15, 2022
Multiple Myeloma Trial in United States (Belantamab Mafodotin, Nirogacestat)
Recruiting
- Multiple Myeloma
- Belantamab Mafodotin
- Nirogacestat
-
Basking Ridge, New Jersey
- +6 more
Oct 5, 2022
Multiple Myeloma Trial in Japan, United States (JNJ-68284528)
Completed
- Multiple Myeloma
- JNJ-68284528
-
Phoenix, Arizona
- +20 more
Oct 5, 2022
Multiple Myeloma Trial in Worldwide (Elranatamab (PF-06863135))
Active, not recruiting
- Multiple Myeloma
- Elranatamab (PF-06863135)
-
Beverly Hills, California
- +75 more
Oct 4, 2022
Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone)
Completed
- Multiple Myeloma
-
Scottsdale, Arizona
- +139 more
Sep 9, 2022
Multiple Myeloma Trial in Worldwide (ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone)
Active, not recruiting
- Multiple Myeloma
- ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone
-
Atlanta, Georgia
- +25 more
Aug 31, 2022
Multiple Myeloma Trial in United States (Carfilzomib, Lenalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Carfilzomib
- +4 more
-
Birmingham, Alabama
- +11 more
Aug 11, 2022
Multiple Myeloma Trial in Worldwide (Daratumumab Subcutaneous (SC) Administration, Recombinant Human Hyaluronidase [rHuPH20]) SC
Active, not recruiting
- Multiple Myeloma
- Daratumumab Subcutaneous (SC) Administration
- Recombinant Human Hyaluronidase [rHuPH20]) SC Administration
-
Atlanta, Georgia
- +11 more
Aug 11, 2022
Multiple Myeloma Trial in United States (procedure, drug, biological)
Completed
- Multiple Myeloma
- Tumor Cell Collection
- +6 more
-
San Francisco, California
- +14 more
Jul 11, 2022
Multiple Myeloma Trial in United States (Cilta-cel, Lymphodepleting Therapy (Cyclophosphamide and Fludarabine))
Recruiting
- Multiple Myeloma
- Cilta-cel
- Lymphodepleting Therapy (Cyclophosphamide and Fludarabine)
-
Duarte, California
- +23 more
Aug 1, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin frozen liquid, Belantamab mafodotin lyophilized powder)
Active, not recruiting
- Multiple Myeloma
- Belantamab mafodotin frozen liquid
- Belantamab mafodotin lyophilized powder
-
New Haven, Connecticut
- +58 more
Jul 27, 2022